AbbVie (ABBV) stock is in focus as the company files lawsuit over Medicare's decision to select its Botox therapy for prciing negotiations. Read more here.
Q2 2026 Earnings Call February 10, 2026 6:00 PM ESTCompany ParticipantsMark DehringGordon NaylorKen Lim - Chief Financial ...
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present nine abstracts from its hereditary angioedema (HAE) portfolio at the 2026 American Academy of Allergy, ...
About navenibart Navenibart is an investigational YTE-modified monoclonal antibody inhibitor of plasma kallikrein, an established and safe mechanism, currently being evaluated in clinical trials for ...
Last year, people in the U.S. made an estimated $4.7 billion selling their plasma. Donation centers are popping up in ...
Baller Alert on MSN
More than 200,000 middle-class Americans a day are cashing in their plasma to stay afloat as household costs surge
More middle-class Americans are turning to the plasma industry as a source of extra income, fueling rapid growth in a business that now stretches into suburbs, college towns, and shopping […] ...
In 2020, as many as 5.8 million Americans were living with Alzheimer’s Disease (AD)—a number projected to nearly triple to 14 million people by 2060. 1 As changes in the brain can begin years before ...
The gut microbiota plays a crucial role in regulating host immunity, metabolism and inflammation, with accumulating evidence linking its composition and function to the development and progression of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results